The 11,348,266 common shares were acquired pursuant to a prospectus
exemption contained in section 2.11 of Regulation 45-106 respecting
Prospectus and Registration Exemptions (Québec) and represent 4.13%
of the issued and outstanding common shares of Medicago. Following this
transaction, the holding of PM Investments in Medicago consists of
109,957,066 common shares representing 40% of all of the issued and
outstanding common shares of Medicago. The balance of 164,935,599 common
shares of Medicago, representing 60% of all issued and outstanding
common shares of Medicago, are owned by
This most recent acquisition of common shares was made for investment purposes. Until Medicago ceases to be a reporting issuer, PMI may, in accordance with applicable securities laws, make additional investments in, or disposition of, securities of Medicago, including additional purchases of Medicago common shares.
This press release is not an admission that MTPC and its affiliates and subsidiaries own or control any described security or are a joint actor with PM Investments or any of its affiliates.
Philip Morris International Inc.
New York: +1 (917) 663 2233
Lausanne: +41 (0)58 242 4666
Lausanne: +41 (0)58 242 4500